• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·4107.TWO
Share

Bioteque Corporation Stocks

NT$ 116.5Last Updated 24.06.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

NT$ 252.76M

NT$ 116.5
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in Taipei, Taiwan, in 1991, Bioteque Corporation operates as a global manufacturer and supplier of medical devices, serving markets across Asia, South America, North America, and other international regions. The company specializes in a diverse range of medical disposables, critical for applications such as hemodialysis access and endovascular treatments. Its comprehensive product line features dialysis equipment, including bloodlines, A.V.F. needles, and hemodialysis catheters; interventional radiology solutions like pigtail drainage catheter sets and introducer sets; and urology essentials such as ureteral stent sets and urine collection bags. Furthermore, Bioteque offers IV administration products, including PVC infusion bags and twist-off ports; respiratory care items like closed suction catheters and endotracheal tubes; and a suite of vascular access products, including angiographic catheters, PTA balloon dilatation catheters, and guidewires. The company also manufactures a wide array of specialized medical components, such as dialyzer connectors, various luer lock connectors, filters, clamps, and transducer protectors, alongside medical masks.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.06.2026 13:03

Elon Musk Is No Longer a Trillionaire — Bloomberg

24.06.2026 11:37

Mag7 shares have experienced their biggest sell-off in over a year. What's next?

24.06.2026 10:35

Top Stories This Morning: Asia Recovers After Sell-Off, SpaceX Raises $25 Billion

24.06.2026 09:00

Apollo and Morgan Stanley have once again restricted withdrawals from private credit funds

24.06.2026 08:00

Alibaba has filed a lawsuit against the Pentagon over allegations of ties to the Chinese military

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026